Abstract:Cardiac remodeling is an end-stage manifestation of multiple cardiovascular diseases, and microRNAs are involved in a variety of posttranscriptional regulatory processes. miR-363-5p targeting Thrombospondin3 (THBS3) has been shown to play an important regulatory role in vascular endothelial cells, but the roles of these two in cardiac remodeling are unknown. Firstly, we established an in vivo model of cardiac remodeling by transverse aortic narrow (TAC), and then we stimulated a human cardiomyocyte cell line (AC16) and a human cardiac fibroblast cell line (HCF) using 1 μmol/L angiotensin II (Ang II) to establish an in vitro model of cardiac hypertrophy and an in vitro model of myocardial fibrosis, respectively. In all three of the above models, we found a significant decreasing trend of miR-363-5p, suggesting that it plays a key regulatory role in the occurrence and development of cardiac remodeling. Subsequently, overexpression of miR-363-5p significantly attenuated myocardial hypertrophy and myocardial fibrosis in vitro as evidenced by reduced the area of AC16, the cell viability of HCFs, the relative expression of the protein of fetal genes (ANP, BNP, β-MHC) and fibrosis marker (collagen I, collagen III, α-SMA), whereas inhibition of miR-363-5p expression showed the opposite trend. In addition, we also confirmed the targeted binding relationship between miR-363-5p and THBS3 by dual luciferase reporter gene assay, and the expression of THBS3 was directly inhibited by miR-363-5p. Moreover, overexpression of miR-363-5p with THBS3 simultaneously partially eliminated the delaying effect of miR-363-5p on myocardial hypertrophy and myocardial fibrosis in vitro. In conclusion, Overexpression of miR-363-5p attenuated the prohypertrophic and profibrotic effects of Ang II on AC16 and HCF by a mechanism related to the inhibition of THBS3 expression.

MiR-10a and MiR-10b Target the 3′-Untranslated Region of TBX5 to Repress Its Expression

Cardiac Hypertrophy and Dysfunction Induced by Overexpression of Mir-214 in Vivo

A TBX5 3′UTR Variant Increases the Risk of Congenital Heart Disease in the Han Chinese Population

Identification of miR-20b-5p as an inhibitory regulator in cardiac differentiation via TET2 and DNA hydroxymethylation

Aberrant expression of miR-29b-3p influences heart development and cardiomyocyte proliferation by targeting NOTCH2

The TBX1/miR-193a-3p/TGF-β2 Axis Mediates CHD by Promoting Ferroptosis

Mild Decrease in TBX20 Promoter Activity is a Potentially Protective Factor Against Congenital Heart Defects in the Han Chinese Population.

Abstract P331: Upregulated TBX1 by Genetic Variants Are Associated with Human Congenital Heart Disease

Mir-10B-5p Regulates 3T3-L1 Cells Differentiation by Targeting Apol6.

microRNA EXPRESSION PROFILING OF CARDIAC TISSUE DURING FETAL DEVELOPMENT 1251 vital role by regulating heart gene expression in heart

Microrna-340-5p Functions Downstream Of Cardiotrophin-1 To Regulate Cardiac Eccentric Hypertrophy And Heart Failure Via Target Gene Dystrophin

MircroRNA-10b Promotes Human Embryonic Stem Cell-Derived Cardiomyocyte Proliferation Via Novel Target Gene LATS1.

Roles of Mir-1-1 and Mir-181c in Ventricular Septal Defects

MicroRNA miR-92b-3p regulation of a cardiovascular gene regulatory network in the developing branchial arches

Microrna363-5p targets thrombospondin3 to regulate pathological cardiac remodeling

Tbx20 regulates a genetic program essential to adult mouse cardiomyocyte function.

Micrornas in Cardiovascular Development

MicroRNA Deregulation in Right Ventricular Outflow Tract Myocardium in Nonsyndromic Tetralogy of Fallot.

Kctd10 Regulates Heart Morphogenesis by Repressing the Transcriptional Activity of Tbx5a in Zebrafish

Microrna Expression Profiling of Heart Tissue During Fetal Development

Expression of Cx43-related microRNAs in patients with tetralogy of Fallot